8 Jun 2015 14:56
AstraZeneca: Morgan Stanley lifts target price to 4,500p from 4,300p, reiterates underweight. BG Group: Canaccord Genuity improves target price to 1,300p from 1,016p and downgrades to hold. GlaxoSmithKline: Deutsche Bank raises target price to 1,600p from 1,300p and reiterates hold. Tate&Lyle: Num
Read more